Róbert Sike
Impact in
- Genetics top 10%
- Inflammatory Bowel Disease
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in ⓘ
- Genetics 7
- Inflammatory Bowel Disease 7
- Chronic Lymphocytic Leukemia Research 7
-
- Chronic Myeloid Leukemia Treatments 4
- Co-authors
- Annegret Van der Aa (5 shared papers)Stefan Schreiber (6 shared papers)Tanja Kuehbacher (7 shared papers)Maria Kłopocka (7 shared papers)Robert Petryka (4 shared papers)Xavier Roblin (7 shared papers)Séverine Vermeire (7 shared papers)Pille Harrison (7 shared papers)
- Journals
- Gastroenterology (3 papers)Journal of Crohn s and Colitis (2 papers)The Lancet (1 paper)PubMed (2 papers)
In The Last Decade
Róbert Sike
9 papers receiving 370 citations
Hit Papers
Peers
Comparison fields: 5 of 40
- Genetics 258
- Hematology 76
- Rheumatology 91
- Immunology 109
- Epidemiology 152
Countries citing papers authored by Róbert Sike
This map shows the geographic impact of Róbert Sike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Róbert Sike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Róbert Sike more than expected).
Fields of papers citing papers by Róbert Sike
This network shows the impact of papers produced by Róbert Sike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Róbert Sike. The network helps show where Róbert Sike may publish in the future.
Co-authors
The 23 scholars most cited alongside Róbert Sike, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2016 | 344 |
| 2 | 2016 | 9 | |
| 3 | [Helicobacter pylori infection in diabetic patients]. | 1999 | 9 |
| 4 | Filgotinib, a selective JAK1 inhibitor, induces clinical remission in patients with moderate-to-severe Crohn's disease: interim analysis from the Phase 2 FITZROY study | 2016 | 5 |
| 5 | 2017 | 4 | |
| 6 | [Comparison of the effectiveness and tolerability of the saccharosum-sennosid-B solution and sodium-picosulfate in preparation for colonoscopy. Prospective, multicenter, randomized study]. | 2003 | 2 |
| 7 | 2017 | 1 | |
| 8 | 2017 | 1 | |
| 9 | 2017 | 1 |
About Róbert Sike
Róbert Sike is a scholar working on Genetics, Genetics, Hematology, Pathology and Forensic Medicine and Surgery, having authored 9 papers that have together received 376 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (7 papers), Chronic Lymphocytic Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (4 papers), Lymphoma Diagnosis and Treatment (2 papers), Eosinophilic Esophagitis (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper), Helicobacter pylori-related gastroenterology studies (1 paper) and Colorectal Cancer Screening and Detection (1 paper). The work is most often cited by research in Genetics (258 citations), Hematology (76 citations), Rheumatology (91 citations), Immunology (109 citations) and Epidemiology (152 citations). Róbert Sike has collaborated with scholars based in Hungary, Poland and Russia. Frequent co-authors include Annegret Van der Aa, Stefan Schreiber, Tanja Kuehbacher, Maria Kłopocka, Robert Petryka, Xavier Roblin, Séverine Vermeire, Pille Harrison, Adrian Goldiș and Chantal Tasset. Their work appears in journals such as Gastroenterology, Journal of Crohn s and Colitis, The Lancet and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.